Brief: Actuate Therapeutics Announces Closing Of $17.25 Million Public Offering Of Common Stock, Including Full Exercise Of Over-Allotment Option
11/09/2025 22:09
Sept 11 (Reuters) - Actuate Therapeutics Inc ACTU.O: ACTUATE THERAPEUTICS ANNOUNCES CLOSING OF $17.25 MILLION PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION Source text: ID:nGNXbNxjKv Further company coverage: ACTU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsHealth Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing